免疫原性-话题@MedSci

#免疫原性#

60篇内容 | 1283人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1393802, encodeId=f57b1393802e3, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=CELL：LSD1缺失增强肿瘤免疫原性, objectType=article, longId=141756, objectId=e3f7141e564b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3f7141e564b, replyNumber=0, likeNumber=40, createdTime=2018-06-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3f7141e564b, moduleTitle=CELL：LSD1缺失增强肿瘤免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3f7141e564b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393801, encodeId=6721139380137, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=CELL：研究人员发现具有不同免疫原性的晚期前列腺癌, objectType=article, longId=140952, objectId=f7fb14095239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7fb14095239, replyNumber=0, likeNumber=0, createdTime=2018-06-18, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7fb14095239, moduleTitle=CELL：研究人员发现具有不同免疫原性的晚期前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7fb14095239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393800, encodeId=8c00139380040, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=比较SB3（曲妥珠单抗生物仿制药）和曲妥珠单抗治疗HER2阳性早期乳腺癌的III期研究：最终安全性，免疫原性和存活, objectType=article, longId=136871, objectId=94111368e1b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94111368e1b3, replyNumber=0, likeNumber=32, createdTime=2018-05-01, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94111368e1b3, moduleTitle=比较SB3（曲妥珠单抗生物仿制药）和曲妥珠单抗治疗HER2阳性早期乳腺癌的III期研究：最终安全性，免疫原性和存活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94111368e1b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393799, encodeId=a1941393e9931, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Ann Rheum Dis：阿达木单抗生物类似物BI 695501和修美乐对中重度活动性类风湿性关节炎具有相似疗效、安全性和免疫原性, objectType=article, longId=136088, objectId=8b931360884f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b931360884f, replyNumber=0, likeNumber=31, createdTime=2018-04-23, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b931360884f, moduleTitle=Ann Rheum Dis：阿达木单抗生物类似物BI 695501和修美乐对中重度活动性类风湿性关节炎具有相似疗效、安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b931360884f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393798, encodeId=8b0f1393e982b, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=J Rheumatol：类风湿性关节炎中抗风湿药物和疫苗免疫原性的Meta分析, objectType=article, longId=133972, objectId=7cc01339e260, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cc01339e260, replyNumber=0, likeNumber=29, createdTime=2018-04-03, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cc01339e260, moduleTitle=J Rheumatol：类风湿性关节炎中抗风湿药物和疫苗免疫原性的Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cc01339e260)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393797, encodeId=e0bf1393e9736, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎中甲氨蝶呤暂时停药2周对季节性流感疫苗免疫原性的影响, objectType=article, longId=133695, objectId=71af1336951a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71af1336951a, replyNumber=0, likeNumber=28, createdTime=2018-03-30, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71af1336951a, moduleTitle=Ann Rheum Dis：类风湿性关节炎中甲氨蝶呤暂时停药2周对季节性流感疫苗免疫原性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71af1336951a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393796, encodeId=98d51393e96c6, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JCI：Dinaciclib诱导免疫原性细胞死亡并增强PD-1抗体介导的肿瘤抑制, objectType=article, longId=130728, objectId=7b92130e289e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b92130e289e, replyNumber=0, likeNumber=29, createdTime=2018-02-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b92130e289e, moduleTitle=JCI：Dinaciclib诱导免疫原性细胞死亡并增强PD-1抗体介导的肿瘤抑制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b92130e289e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393795, encodeId=f5391393e9585, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=ANN RHEUM DIS：类风湿关节炎由英夫利昔单抗转为SB2后的安全性、免疫原性和疗效, objectType=article, longId=116968, objectId=12d511696824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12d511696824, replyNumber=0, likeNumber=33, createdTime=2017-10-22, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12d511696824, moduleTitle=ANN RHEUM DIS：类风湿关节炎由英夫利昔单抗转为SB2后的安全性、免疫原性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12d511696824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393794, encodeId=2c331393e9432, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Br J Dermatol：治疗银屑病，生物仿制药的ABP 501与阿达木单抗的疗效、安全性、免疫原性相似, objectType=article, longId=107219, objectId=a78110e219d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a78110e219d2, replyNumber=0, likeNumber=35, createdTime=2017-08-01, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a78110e219d2, moduleTitle=Br J Dermatol：治疗银屑病，生物仿制药的ABP 501与阿达木单抗的疗效、安全性、免疫原性相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a78110e219d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393793, encodeId=6f761393e930f, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=LANCET ：健康成人mRNA狂犬疫苗的安全性和免疫原性研究——在人类身上进行的首例试验, objectType=article, longId=106866, objectId=36db1068662f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36db1068662f, replyNumber=0, likeNumber=26, createdTime=2017-07-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36db1068662f, moduleTitle=LANCET ：健康成人mRNA狂犬疫苗的安全性和免疫原性研究——在人类身上进行的首例试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36db1068662f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393792, encodeId=946e1393e920d, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=SCI REP：转磺酶的LC-MS / MS定量比传统的免疫原性方法在确定人类肝脏SULT活性方面更好：精密医学的意义, objectType=article, longId=102788, objectId=9cc2102e8885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cc2102e8885, replyNumber=0, likeNumber=44, createdTime=2017-06-23, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cc2102e8885, moduleTitle=SCI REP：转磺酶的LC-MS / MS定量比传统的免疫原性方法在确定人类肝脏SULT活性方面更好：精密医学的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cc2102e8885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393791, encodeId=07ab1393e9120, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=LANCET：rVSV∆G-ZEBOV-GP埃博拉疫苗候选物的安全性和免疫原性, objectType=article, longId=101493, objectId=8386101493df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8386101493df, replyNumber=0, likeNumber=32, createdTime=2017-06-12, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8386101493df, moduleTitle=LANCET：rVSV∆G-ZEBOV-GP埃博拉疫苗候选物的安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8386101493df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393790, encodeId=79121393e90d5, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet：重组腺病毒5型载体的埃博拉病毒疫苗的安全性和免疫原性评估, objectType=article, longId=85688, objectId=454085688fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=454085688fc, replyNumber=0, likeNumber=30, createdTime=2016-12-29, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=454085688fc, moduleTitle=Lancet：重组腺病毒5型载体的埃博拉病毒疫苗的安全性和免疫原性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=454085688fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393789, encodeId=37081393e89d3, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：9价HPV疫苗在男孩和女孩接种2次与妇女接种3次的免疫原性比较, objectType=article, longId=82898, objectId=c809828985e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c809828985e, replyNumber=0, likeNumber=43, createdTime=2016-11-24, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c809828985e, moduleTitle=JAMA：9价HPV疫苗在男孩和女孩接种2次与妇女接种3次的免疫原性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c809828985e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393788, encodeId=d25c1393e885f, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Infect Dis：阿奇霉素对口服脊髓灰质炎疫苗的免疫原性有什么影响？, objectType=article, longId=77012, objectId=f02de7012a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f02de7012a0, replyNumber=0, likeNumber=46, createdTime=2016-09-10, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f02de7012a0, moduleTitle=Lancet Infect Dis：阿奇霉素对口服脊髓灰质炎疫苗的免疫原性有什么影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f02de7012a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393787, encodeId=139d1393e8787, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：对2种埃博拉病毒疫苗安全性和免疫原性的评价, objectType=article, longId=66900, objectId=594d66900e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=594d66900e9, replyNumber=0, likeNumber=35, createdTime=2016-04-22, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=594d66900e9, moduleTitle=JAMA：对2种埃博拉病毒疫苗安全性和免疫原性的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=594d66900e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393786, encodeId=42311393e8665, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=AIM：两种新型HIV-1预防疫苗的安全性和免疫原性评价, objectType=article, longId=63011, objectId=4a2663011bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2663011bb, replyNumber=0, likeNumber=32, createdTime=2016-02-05, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2663011bb, moduleTitle=AIM：两种新型HIV-1预防疫苗的安全性和免疫原性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a2663011bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393785, encodeId=50d71393e8503, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Infect Dis：新型单价高剂量灭活脊髓灰质炎病毒2型疫苗的免疫原性和安全性较好, objectType=article, longId=60985, objectId=6e8760985e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e8760985e3, replyNumber=0, likeNumber=26, createdTime=2015-12-23, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e8760985e3, moduleTitle=Lancet Infect Dis：新型单价高剂量灭活脊髓灰质炎病毒2型疫苗的免疫原性和安全性较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e8760985e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393784, encodeId=75641393e8465, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Infect Dis：RV3-BB新生儿轮状病毒疫苗对于婴儿和新生儿的安全性和免疫原性良好, objectType=article, longId=55479, objectId=9d23554e95a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d23554e95a, replyNumber=0, likeNumber=44, createdTime=2015-08-30, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d23554e95a, moduleTitle=Lancet Infect Dis：RV3-BB新生儿轮状病毒疫苗对于婴儿和新生儿的安全性和免疫原性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d23554e95a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393783, encodeId=aea61393e833a, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet：中国江苏泰州新型埃博拉疫苗安全性和免疫原性的研究, objectType=article, longId=48640, objectId=c0e1486409e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e1486409e, replyNumber=0, likeNumber=31, createdTime=2015-03-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e1486409e, moduleTitle=Lancet：中国江苏泰州新型埃博拉疫苗安全性和免疫原性的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e1486409e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫原性

2020-05-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

CELL：LSD1缺失增强肿瘤免疫原性

2018-06-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

CELL：研究人员发现具有不同免疫原性的晚期前列腺癌

2018-06-18

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

比较SB3（曲妥珠单抗生物仿制药）和曲妥珠单抗治疗HER2阳性早期乳腺癌的III期研究：最终安全性，免疫原性和存活

2018-05-01

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Ann Rheum Dis：阿达木单抗生物类似物BI 695501和修美乐对中重度活动性类风湿性关节炎具有相似疗效、安全性和免疫原性

2018-04-23

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

J Rheumatol：类风湿性关节炎中抗风湿药物和疫苗免疫原性的Meta分析

2018-04-03

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Ann Rheum Dis：类风湿性关节炎中甲氨蝶呤暂时停药2周对季节性流感疫苗免疫原性的影响

2018-03-30

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JCI：Dinaciclib诱导免疫原性细胞死亡并增强PD-1抗体介导的肿瘤抑制

2018-02-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

ANN RHEUM DIS：类风湿关节炎由英夫利昔单抗转为SB2后的安全性、免疫原性和疗效

2017-10-22

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Br J Dermatol：治疗银屑病，生物仿制药的ABP 501与阿达木单抗的疗效、安全性、免疫原性相似

2017-08-01

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

LANCET ：健康成人mRNA狂犬疫苗的安全性和免疫原性研究——在人类身上进行的首例试验

2017-07-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

SCI REP：转磺酶的LC-MS / MS定量比传统的免疫原性方法在确定人类肝脏SULT活性方面更好：精密医学的意义

2017-06-23

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

LANCET：rVSV∆G-ZEBOV-GP埃博拉疫苗候选物的安全性和免疫原性

2017-06-12

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet：重组腺病毒5型载体的埃博拉病毒疫苗的安全性和免疫原性评估

2016-12-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：9价HPV疫苗在男孩和女孩接种2次与妇女接种3次的免疫原性比较

2016-11-24

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Infect Dis：阿奇霉素对口服脊髓灰质炎疫苗的免疫原性有什么影响？

2016-09-10

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：对2种埃博拉病毒疫苗安全性和免疫原性的评价

2016-04-22

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

AIM：两种新型HIV-1预防疫苗的安全性和免疫原性评价

2016-02-05

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Infect Dis：新型单价高剂量灭活脊髓灰质炎病毒2型疫苗的免疫原性和安全性较好

2015-12-23

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Infect Dis：RV3-BB新生儿轮状病毒疫苗对于婴儿和新生儿的安全性和免疫原性良好

2015-08-30

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet：中国江苏泰州新型埃博拉疫苗安全性和免疫原性的研究

2015-03-28

科室
- - 订阅+
  - 更多科室
工具
服务